GCI | ||
|---|---|---|
OUTLOOK RATING 1..100 | 53 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 93 Overvalued | |
PROFIT vs RISK RATING 1..100 | 70 | |
SMR RATING 1..100 | 100 | |
PRICE GROWTH RATING 1..100 | 63 | |
P/E GROWTH RATING 1..100 | 91 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| CWB | GCI | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 79% | 3 days ago 89% |
| Stochastic ODDS (%) | 3 days ago 72% | 3 days ago 81% |
| Momentum ODDS (%) | 3 days ago 80% | 3 days ago 83% |
| MACD ODDS (%) | 3 days ago 68% | 3 days ago 77% |
| TrendWeek ODDS (%) | 3 days ago 81% | 3 days ago 80% |
| TrendMonth ODDS (%) | 3 days ago 78% | 3 days ago 87% |
| Advances ODDS (%) | 3 days ago 79% | 4 days ago 78% |
| Declines ODDS (%) | 5 days ago 73% | 7 days ago 84% |
| BollingerBands ODDS (%) | 3 days ago 79% | 3 days ago 79% |
| Aroon ODDS (%) | 3 days ago 75% | 3 days ago 89% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SBIO | 42.48 | 0.42 | +0.99% |
| ALPS Medical Breakthroughs ETF | |||
| AGEM | 38.14 | 0.19 | +0.51% |
| abrdn Emerging Markets Dividend Act ETF | |||
| BMED | 28.46 | 0.08 | +0.29% |
| iShares Health Innovation Active ETF | |||
| DGS | 57.13 | 0.08 | +0.14% |
| WisdomTree Emerging Markets SmCp Div ETF | |||
| IDLV | 33.62 | -0.04 | -0.11% |
| Invesco S&P Intl Dev Low Vol ETF | |||